Common Stock, Shares, Outstanding of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Achilles Therapeutics plc quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 41.1M shares, a 0.35% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.1M +142K +0.35% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 41.1M +150K +0.37% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 40.9M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 40.9M +329K +0.81% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 40.6M +36.2M +825% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 4.39M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.